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Major histocompatibility complex (MHC) 1 restriction is a term used to indicate 
the  obligate  recognition  of  self-MHC  products  by  immune  T  cells.  In  the 
particular case of helper T  cells (TH), immune response-associated (Ia) molecules 
are  recognized  in  context  with  foreign  antigens  on  the  surface  of antigen- 
presenting cells (APC). This dual recognition of antigen plus Ia is a fundamental 
aspect of immune response (Ir) gene control of T  cell antigen-induced respon- 
siveness (reviewed in reference 1). Earlier reports using anti-Ia antisera to inhibit 
the proliferation of bulk populations ofT cells strongly suggested that Ia antigens 
were involved in the immune response (2-4). Recent studies have demonstrated 
that  Ia antigens are directly responsible for certain Ir gene effects. First,  some 
antigen-reactive  T  cell  clones,  restricted  to  Ia  antigens  of responder  strain  b, 
could not respond to antigen in the context of Ia antigens of the congenic strain 
B6C-H-2bm~2(bml 2) (5). The bml 2 strain has a mutation in the Aa  b polypeptide 
that results in a structurally altered Ia molecule of haplotype b (6). Second, there 
was a direct correlation between the level of expression of ~n Ia antigen and the 
ability of APC  to present antigen  to T  cell  clones (7,  8).  Third,  proliferative 
responses of appropriate T  cells could be inhibited by monoclonal anti-Ia anti- 
bodies directed  toward  the  APC  (9-1 1).  These antibody-blocking studies  sug- 
gested that monoclonal anti-Ia antibodies could mask and/or alter T  cell recog- 
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nition site(s) on APC Ia molecules and that this effect alone was responsible for 
certain  Ir gene functions.  The  specificity of antibody blocking correlated  with 
haplotype specificity and I-region mapping of the Ir gene effect. Thus, monoclo- 
nal Tn cells and monoclonal anti-Ia antibodies were instrumental in showing that 
recognition of Ia on APC by T  cells is the basis for certain Ir gene phenomena. 
The  combination  of monoclonal  anti-Ia  antibodies  and  Ia-restricted  T  cell 
clones also proved decisive in analyzing T  cell recognition of "hybrid" Ia antigens 
(5,  12,  13). These molecules were found to exist on cells of F~ animals and to be 
formed by the free combinatorial association of parental Ia a and/3 polypeptides 
that associate noncovalently to form an Ia molecule. For example, in F~ (b ×  k) 
animals, there exist in addition to parental A~bA~  b and A~kAe  k molecules, hybrid 
A,~kAt~  b and  A~bA~  k Ia  molecules.  It  could further  be shown  that  both hybrid 
combinations (A~bAe  k and A~kAo  b) could be specifically recognized by particular 
T cell clones. T  cell clones that recognized F~ hybrid Ia antigens (but not parental 
molecules)  were tested  for  inhibition  of proliferation  of monoclonal  anti-I-A k 
antibodies. The clones could be sharply divided into two groups: one group was 
inhibited  by antibody  10-2.16  and  not by antibody H116-32,  the other group 
was inhibited  by H116-32  but not by 10-2.16.  We then  showed biochemically 
that  10-2.16 reacted with AakIa chains,  while H116-32 reacted with A~  k chains. 
Thus,  clones blocked by antibody  10-2.16  recognized  A~bAe  k molecules, those 
blocked by HI 16-32 recognized A~kA~  b molecules (I4). 
In addition to mapping T  cell recognition to a particular Ia molecule, it would 
be instructive  to  map  T  cell  restriction  sites on a  single  Ia molecule.  Current 
information from gene sequencing and protein studies suggest that Ia molecules 
may  fold  into  two  structural  domains  (15-18).  Similarly,  serological  studies 
indicate that Ia molecules have at least three distinct "epitope clusters" (19, 20), 
which  may also be  related  to  protein  three-dimensional  structure.  We  would 
ultimately like to know the nature of the T  cell recognition sites, the determinants 
recognized by antibodies, and the structural  basis of these sites. Given the data 
suggesting  multiple  structural  domains of an  Ia molecule, we wanted to know 
whether there existed more than one functional site on an Ia molecule that could 
be demonstrated  with anti-Ia  inhibition  of T  cell proliferation.  Therefore,  we 
utilized a panel of monoclonal anti-I-A k antibodies to test inhibition of prolifer- 
ation  of a  panel  of T  cell  clones  that  recognized  I-A  b/k hybrid  molecules.  A 
complex blocking  pattern  would indicate  multiple  specificities of T  cells for a 
given Ia molecule analogous to the multiple epitopes recognized on I-A molecules 
by anti-I-A antibodies. Our results indicate that multiple functional sites exist on 
a  given Ia molecule. These data complement and extend previous results from 
our laboratory that  show the existence of more than  one functional  site per Ia 
molecule by genetic means  (21).  An additional  important  consequence of this 
study  is  the  mapping  of several  antibody  specificities  as  being  a  or  /3  chain 
determined. 
Materials and Methods 
Mice.  The adult inbred and F1 hybrid mice were bred in our animal  facilities at the 
Department of Medicine, Stanford University or purchased from The Jackson Laboratory, 
Bar Harbor, ME. Mice of either sex were used. Mouse strains used were (C57BL 6/JXA/ 706  MULTIPLE  T  CELL  SITES  DEFINED  USING  ANTI-IA  ANTIBODIES 
J)F, and B10.A(4R)x57BL10/J. 
Long-term Cultured  T Cell Clones.  Antigen-reactive T cell clones were established from 
immunized (bxk)F1 mice. Complete culture media and antigens (GAT, (T,G)-A--L, KLH 
and myoglobin) were described previously (5,  12,  22,  23).  The antigen specificities of 
the  clone are:  26.17:myoglobin,  2eSA12,  2eSA13:TGAL,  NAO:KLH,  12.5.a.1,  and 
12.5.a.31-GAT. All these clones were I-A  b/k restricted. The clones were serially restim- 
utated with antigen and irradiated syngeneic spleen cells in fresh media every 10-14 d. 
The T  cell clones were used for assay more than 10 d after stimulation with antigen and 
APC. 
Monoclonal Antibodies.  Anti-I-A  k monoclonal antibodies (mAb) 10-2.16 and H116-32 
were described previously (24, 25). All other anti-I-A  k mAb were developed and reported 
by Pierres and co-workers (20,  26).  Antibodies were purified using Protein A  affinity 
chromatography and dissolved in  phosphate-buffered saline,  pH  7.4  (~1  mg/mi).  For 
blocking assay of T cell proliferation, 2.5 #1 of antibody solution in 200 #1 of medium was 
used. Preliminary dose response experiments showed that this was the maximum amount 
of antibody that could be added to the cultures which did not seriously inhibit proliferation 
nonspecifically (nonspecific inhibition usually <20%). 
Blocking Assay of Cloned T Cell Proliferation.  T  cell clone proliferation assays and assays 
of T  cell blocking of proliferation by anti-I-A  k mAb in vitro were described previously 
(14). Briefly, 104 cloned T  cells were cultured with 106 irradiated spleen cells (APC) and 
an appropriate dose of antigen. For the blocking of T  cell proliferation, antibodies were 
added at the beginning of culture and were present throughout. After 2 d  incubation, 
[~H]thymidine ('H-TdR)  incorporation  was  measured  by  liquid  scintillation  counting 
methods. Counts represent the average of three replicates. In most cases, the replicates 
were  within  10%  of the  mean.  The  variability between  experiments was  greater,  in 
particular for those clones that were only partially blocked. We, therefore, present data 
from one of the experiments in which all the clones were tested simultaneously. Optimal 
amounts  of each  antibody  for  maximal  specific blocking of each  T  cell  clone were 
determined by preliminary dose response experiments. 
Two-dimensional Get Electrophoresis.  Methods of analysis of Ia molecules by two-dimen- 
sional gel electrophoresis (2-D  gels)  were as  described previously (14).  Spleen cells  of 
strains C57BL6 ×  A/J (B6A)F1 or C57BL10 ×  BI0.A(4R)F1 mice were biosynthetically 
radiolabeled with pS]methionine and solubilized in buffer containing 0.5% Triton X- 
100.  These  F1  strains  were  chosen  to  eliminate  the  weak  reactions  with  I-E  region 
molecules sometimes seen in our immunoprecipitation assays (J. Frelinger, unpublished 
data).  Cell  extracts  were  precleared  with  fixed S.  aureus  (Cowan  strain  I)  and  then 
precipitated with  monoclonal anti-Ia antibodies.  Antigen-antibody complexes were ab- 
sorbed to fixed S. aureus (Cowan strain I), and then eluted directly into isoelectric focusing 
buffer. Samples were loaded on the acidic end and separated in the first dimension by 
isoelectric focusing in polyacrylamide gels containing urea and in the second dimension 
by 10% SDS-PAGE under reducing conditions. 
Results 
The Experimental  System ldent~es  T  Cells and Antibodies Recognizing A~  ~ or 
Aa  k 
All the cell lines that are specific for hybrid (B6A)F~  I-A  b/k molecules show a 
clear division  into  two  groups  (10-2.16-group  and  Hl16-32  group)  based  on 
antibody blocking of proliferation. The FI specific T  cell clones are blocked by 
antibody 10-2.16 or H 116-32, but never both. Since previous biochemical studies 
showed that  10-2.16  reacts with A~  k (14,  27,  30) and H116-32 reacts with A~  k 
(14),  it  follows  that  FI  restricted  T  cell  clones  that  are  blocked  by  10-2.16 
recognize A~bAa k molecules; clones blocked by H116-32 recognize A,kAo  b mol- 
ecules. This point is illustrated schematically in  Fig.  1.  We then examined the FRELINGER ET  AL. 
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FIGURE  1.  Schematic  diagram of F,  hybrid I-A  b'~ molecules showing immunoprecipitation 
patterns expected using mcAbs H116-32 and 10-2.16.  HI 16-32 precipitates  A.  k, A~  k, and 
AB  b polypeptides;  10-2.16 precipitates  Aa  k, A=  b, and AB  k polypeptides. 
ability of a number of other anti-I-A k mAb to inhibit T cell proliferation utilizing 
clones that were blocked by either  10-2.16 or H116-32. These clones then act 
as defined reagents  to characterize  the  reactivity of the  new mAb for a  or /3 
chains.  In addition,  we have independently characterized the reactivity of many 
of the mAb by immunoprecipitation.  To date, these two methods of assigning 
the reactivity of the mAb to the a  or/3 chain have agreed. 
Several Antibodies Exhibit a Pattern ofT Cell Inhibition Similar to 10-2.16.  Table 
IA  shows the  proliferation  inhibition  caused  by five mAb  that  behave  nearly 
identically to  10-2.16.  All  of these  antibodies  potently inhibit  proliferation  of 
clones recognizing  A~bAt~  k molecules.  Since none of these antibodies recognize 
Ia molecules of haplotype b, they must bind Ao  k chains. No antibodies in the "10- 
2.16 group" (40N, 39E, 40M, 40F, 39B) block T  cell clones reactive with A,kAa  b 
molecules (Table IA). They all block a control T  cell clone that recognizes A,kAa  k 
(data not presented). 
Antibodies that Inhibit T Cell Clones Reactive with A~kAo  b  Molecules Demonstrate More 
than  One  Functional  Site  on  A,~kA#  b.  In  the  same  experiment,  we  tested  mAb 
blocking  of T  cell  clones  reactive  with  A~kAa  b molecules.  As  was  previously 
demonstrated (14), antibody H 116-32 clearly distinguishes the reactivity pattern 
of I-Ak/b-restricted  T  cell  clones  from  those  that  are  blocked  by the  10.2.16 
group of antibodies. Thus, using antibody H 116-32 as the prototype monoclonal 
anti-I-A, k,  we  selected  a  group  of antibodies  from  the  panel  to  use  to  test 
inhibition  of clones whose proliferation could be blocked by antibody H 116-32 
(Table IB). Several antibodies (39J, 40J, and 39F) blocked only A,kAab-reactive 
clones. These antibodies ("H I 16-32-1ike group"), therefore, recognize A~  k. The 
pattern of inhibition  by the H 116-32 group was quite different from the results 
for the 10-2.16 group. In contrast to the "10-2.16-like" antibodies, the antibodies 
in the H 116-32 group were more restricted in their ability to block the panel of 
T  cell clones recognizing A~kAa  b complexes. Although all three antibodies (39J, 
40J, 39F) which are "H 116-32-1ike" block only A,kAab-reactive clones, they do 
not block every such clone  tested and  block less effectively than  the  "10.2.16 
group". Antibody 39J reacts very much like H 116-32 in that it blocks prolifera- 708  MULTIPLE T  CELL  SITES  DEFINED  USING  ANTI-IA ANTIBODIES 
TABLE  I 
Blocking of T Cell Clones by Monoclonal  Antibodies 
Uptake of [3H]Thymidine 
NAO  12.5a.1  12.5.a.31 
A.  Blocking  of antigen-specific A,bAok-restricted T cell clones by monoclonal anti- 
I-Akantibodies. 
No antibody  20,104  7,882  19,552 
10.2.16  270  565  386 
39.E  316  951  1,239 
40.N  271  1,307  835 
40.M  238  592  756 
40.F  383  1,955  8,493 
39.B  4,408  2,573  6,880 
No antibody  20,104  7,882  19,522 
116.32  15,644  8,186  10,481 
39~  13,202  10,205  18,251 
40~  14,008  8,449  16,548 
39.F  12,182  8,181  15,538 
B.  Blocking  of AakA¢b-restricted T cell clones ~  monoclonal anti-I-A* antibodies. 
2eSA 13  2eSA 12  26.17 
No antibody  15,419  33,471  7,235 
116.32  6,213  2,262  3,026 
39~  4,101  10,274  1,674 
40~  4,113  8,173  6,171 
39.F  7,181  19,006  2,682 
No antibody  15,419  33,471  7,235 
10.2.16  13,494  29,776  8,936 
39.E  13,671  32,079  10,291 
40.N  12,178  33,247  9,857 
40.M  10,664  29,404  9,811 
40.F  12,137  31,434  11,333 
39.B  12,243  32,498  9,444 
TABLE  II 
Differential Blocking of Two A~kAa  b Clones 
No antibody  10.2.16  116.32  39F  40J  39j 
2eSA 12  20,249  19,487  4,534  17,289  2,936  4,424 
26.17  19,653  26,640  4,337  4,502  15,574  2,275 
tion  of all  of the  A~kAt~  b clones tested.  Table  II  presents additional  data from 
another  experiment  to clearly show the differential  blocking of antibodies 40J 
and 39F on two of the A~kAab-restricted clones (2eSA12 and 26.17). As can be 
seen from these data, there is quite clearly a difference in the ability of 40J and 
39F to inhibit  recognition  of antigen  by these two separate A,~kAB  b clones. We 
suggest  that  these  patterns  result  from  multiple  T  cell  "epitopes"  (restriction 
sites) per Ia A,kAe  b molecule. 
The Reactivity  of mAb Reactive  with A~  k or A#  k Chains Is Determined  by  2-D  Gel FRELINGER  ET  AL.  709 
Analysh.  We  have  localized  the  binding  of  mAb  to  the  a  or  3  chains  by 
immunoprecipitation  from (b ×  k)F1 spleen cells. All of the mAb reported here 
recognize the k haplotype I-A molecules, but not the b haplotype molecules. We 
can take advantage of the combinatorial association of a  and 3  chains in an  F, 
animal to determine whether a  given monoclonal reacts with an a  or 3 chain.  If 
an antibody reacts with a  3  chain,  it will  precipitate  2 a  chains and  1 3  chain. 
The 10-2.16-like antibodies,  10-2.16, 40M, 39E, and 40N precipitate 2 a chains 
and  1 /3 chain  (A~kAebAa  k) from b  ×  k spleen cell extracts.  Immunoprecipitates 
of three of these antibodies are shown in Fig. 2, a-c.  Hence, we conclude that 
the  10.2-16-like  group of antibodies react with the Aa  k chain.  Conversely, the 
reactivity  of the  H116-32-1ike  antibodies  is  determined  by the  A~  k chain  as 
determined by the same type of 2-D gel analysis (Fig.  2, d-f). These antibodies 
precipitate  1  a  and  2  3  chains  (A~kA~k,At~b). Further  the  patterns  of the  I-A 
molecules precipitated by these antibodies appear identical. The same pattern is 
observed for 39F although this is a relatively weak immunoprecipitating antibody 
(data not shown). These data demonstrate that the H 116-32-1ike group of mAb 
reacts with a specificity determined by the A,  k chain. 
Discussion 
Multiple  Functional  Sites Recognized  by  T  Cell  Clones.  The  results  described 
above demonstrate  that  Ia  molecules of the  configuration  A~kAa  b have  more 
than  one functional  site that  is  used in restricted recognition  by T  helper  cell 
clones. Previously, we had shown that we could determine which Fl-restricted T 
cell clones recognized the A~kAa  b molecule or the A~bAa  k molecule by blocking 
proliferation  with monoclonal anti-I-A k antibodies (14).  Antibody H116-32 in- 
hibits proliferation of A~kAab-reactive T  cell clones and reacts with A~  k chains as 
shown by immunoprecipitation.  In  the present  report,  we found several other 
antibodies that also inhibited A~kAab-reactive clones. These antibodies, however, 
could be subdivided into three groups. The first (represented by 39J) behaved 
identically to H116-32, blocking all of the A~kAab-reactive  T  cells. The second 
(40J) blocked only some of the clones, while the third (39F) blocked other clones. 
The patterns of inhibition of 40J and 39F are not subsets of one another.  In the 
most rigorous analysis, we might argue that the overlapping or subsetting patterns 
differ only in relative affinity of mAb and T  cells for Ia molecules rather  than 
specificity per se. However, differences in affinities cannot explain the differential 
blocking  seen  with  40J  and  39F.  There  are  at  least  two  patterns  of T  cell 
recognition of A~kA~  b molecules. We believe that these different patterns are the 
result of the occurrence of different interaction  sites for various T  cells on the 
A~kAa  b molecule. 
In a  separate paper,  we have argued for the existence of two T  cell sites on 
A,bAo  b molecules in  studies  using  the  I-A  mutant  mouse  B6.-C-H-2  bml~ (21). 
Thus it appears  that  a  given  murine  Ia  molecule can be recognized in several 
different ways by a group of Ia-restricted T  cell clones. This was also suggested 
recently in the guinea pig, using T  cell soft agar colonies (28). 
Since some studies have suggested multiple  "forms"  of Ia a  and 3  chains  of 
certain  haplotypes  (29),  it  might  be suggested  that  we  have  defined  multiple 
forms of A~kAo  b, each with a single T  cell recognition site. By our 2-D gel analysis 710  MULTIPLE  T  CELL  SITES  DEFINED  USING  ANTI-IA ANTIBODIES 
FIGURE 2.  Two-dimensional SDS-PAGE of radiolabeled Ia molecules immunoprecipitated 
from spleen cell extracts of (B6 x  A]J)FI mice (a, d-f) or B10  x  BI0.A(4R) mice (b and c) 
immunoprecipitated by various monoclonal antibodies. The different arrows denote different 
k  k  b  b  a or fl chains: a  solid curved arrows,/3  solid straight arrows, ~  open curved arrow, fl  open 
straight arrow; A denotes actin, and li denotes invariant chain, a, 10.2.16;  b, 40 M; c, 39E; d, 
H116-32; e, 40J;fi 39j. Results are displayed as follows: basic pI, left; acidic pI, right; high 
molecular weight, top; low molecular weight, bottom. 
(Fig. 2),  we find identical forms  of A~  k precipitated by all the antibodies of the 
H116-32-group  (39J,  40J,  39F).  Thus,  we believe the T  cell sites defined above 
are present on the same Ia molecule. 
Assignment  of Alloantigenic  Determinants  to  c~  or  fl  Chains.  As  can  be  seen  in 
Table IA, 10-2.16, an anti-Aa  k antibody, potently inhibits certain T  cell clones-- FRELINGER  ET  AL.  711 
those that  recognize A~bAt~  k Ia molecules.  Five anti-I-A k mAb had very similar 
blocking patterns, although they bound to distinct Ia epitopes (26). We therefore 
analyzed the material precipitated from (b × k)F1 spleen cells by these antibodies 
on 2-D gels. Since the antibodies react with haplotype k and not b and precipitate 
AakAa  b, and  Aa  k,  they must  bind  to  a  site  on  A0  k.  As  a  result,  we assign  the 
determinants recognized by these antibodies to the A#  k chain (Table III). Thus, 
Ia.1  (40N,  39E, and  40M)and  Ia.17  (10-2.16) both  map to the  A~  k  chain.  A 
recent report (19) has also suggested that these Ia specificities are topographically 
close to each other. 
As shown above, the H 116-32 group of antibodies reacts with Aak chains of I- 
A k.  These  antibodies  have  strain  reactivities  similar  to  the  conventional  Ia 
specificities Ia.2 (40J, 39F)and Ia. 19 (39J). These specificities, therefore, should 
reside on the A~  k polypetide chain (Table III). The Ia.2 specificity may represent 
multiple  determinants,  however,  and  at  least  one  mAb  with  Ia.2  specificity 
(11.5.2) is reported to react with Aak. (30) We have not used this particular mAb 
in  our studies.  Thus,  certain  conventional  Ia  specificities may not  map  neatly 
over c~ or  13 with  mAb.  Whether  this  is  a  peculiarity  of Ia.2  or other  private 
specificities or is a more general phenomenon is unclear. It should be noted that 
the antibodies in  Table  IB and  used in  Fig.  2, d-f have distinct specificities as 
demonstrated by competitive binding studies (20). They do, however, react with 
the same "epitope cluster." 
A recent report utilized immunoprecipitation  of isolated a  and 13 chains in an 
attempt to directly localize and unambiguously assign specific alloantigen deter- 
minants  to the  a  or/3 chains  (30).  Three  monoclonals were used in  both that 
study and our current  report:  10-2.16,  39F, and  39J.  In agreement  with these 
studies and those previously reported by us (14) and  Silver et al.  (27),  10.2-16 
maps to the/3 chain.  In addition,  their  unpublished  results in accord with our 
results indicate that  40.F and  40.M  react with the 13 chain  (J.  Freed, personal 
communication).  Kupinski  et al.  (30)  were  unable  to  map  either  39F  or  39J. 
However, since they were unable to map any determinant to the A, chain, their 
results are not consistent with the ones presented here. 
mAb Specificities  Are Determined  by the  a  or 13 Chain,  But  the Binding Site  of the 
Antibody Need Not Be on the Determining Chain.  We wish to emphasize that while 
the simplest interpretation  of our studies is that the mAb react with the a  or 13 
chains alone, an alternative possibility is that the determinants  defined by mAb 
are combinatorial  or conformational,  i.e.,  involve both a  and/3 chains.  In that 
TABLE  III 
Assignment of la Spec~cities to Aa or A[3 Chains 
Chain  Presumed 
recognized  Monoclonal antibody  specificity 
40N, 39E, 40M  Ia 1 
13  10.2.16, H150-13"  Ia 17 
40F*  ?? 
a  40J, 39F, H118-49"  Ia 2 
a  39J, H116-32  Ia 19 
* Determined by blocking of T cell proliferation only. H 118-49 and H 150- 
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case,  antibodies  such  as  Hl16-32  would  precipitate  A, k,  Aa  b,  and  As  k  by 
recognizing  a  determinants  shared  by the  A,kA~  k and  A~kAa  b complexes,  but 
absent from A,~bAa  b and A,~bA¢  k complexes. Thus,  a  major contribution  would 
still  be  made  by A,  k.  To  be  concise,  in  some  instances  we  have  utilized  the 
phrases "chain specific" or "reacting with the a  or/3 chains" in place of the more 
accurate phrase  "antibodies with a  or/3 chain determined specificity." We wish 
to reiterate that while the reactions with the antibodies are determined by the a 
or ~ chain,  the actual physical binding site of the antibody may not be on that 
chain. 
T  Cell Clone Recognition  May Involve Both  a  and ~3 Chains.  The blocking of T 
cell clones by anti-a or anti-/3 reacting antibodies does not imply that the T  cell 
recognition  site is located only on one chain or the other.  Indeed,  since the T 
cell clones studied here are all reactive with only the hybrid I-A  wk molecules, it 
appears  that  the  T  cells  recognize  combinational  determinants  influenced  by 
both a  and ~ chains. Whether the T  cells can recognize A~ or Aa chains like the 
mAb may be addressed by DNA-mediated transfection or by using heterozygous 
Ia mutant cell lines (31). Finally, in view of data presented above concerning the 
variable patterns of blocking of A~k-reactive mAb, it may be questioned why the 
Anti-As  k antibodies show such a uniformly potent effect on all susceptible clones. 
There are at least four possible reasons: (a) many of the Aa  k mAb are directed 
to a single region of As  k that is recognized by all T  cell clones using this molecule 
in Ia restriction-recognition;  (b) the Ao  k chain is exquisitely sensitive to confor- 
mational  changes  induced  upon  antibody  binding,  such  that  binding  of any 
appropriate mAb alters T  cell recognition of A,bAak; (c) the anti-I-A k mAb tested 
were  made  via  haplotype  s  and  anti-k  immunization,  which  may  give  only  a 
limited repertoire  of particularly  high  affinity anti-Aa k antibodies;  and  (d) the 
presence of the two disulfide bonds in the/3 chain constrain  its structure  more 
than  the  one disulfide in the a  chain  and thus make it a  better ligand  for the 
mAb.  At present,  there  is  no clear choice among  these  possibilities.  We  have 
presented  data  in  a  previous  report  (21)  that  demonstrates  that  the  second 
possibility does occur: certain antibodies do inhibit T  cell proliferation by binding 
to sites that are distant from the T  cell recognition site. 
Speculations  on  the  Location  of Restriction  Sites.  It  seems  likely  from  protein 
structural  studies and nucleotide sequence analysis that  both Ia a  and/3 chains 
fold  into  two  structural  domains  (15-18).  As  a  consequence  of our  results 
presented here and elsewhere showing multiple functional sites per Ia molecule, 
it will be of interest to precisely define where the T  cell recognition sites are on 
Ia molecules. One alternative is that there are T  cell recognition sites on each of 
the Ia structural  domains.  Another possibility is that  there are multiple  T  cell 
recognition sites on a  single Ia domain.  At this point, we cannot clearly choose 
between these alternatives. However, recent DNA sequence data of the A~ genes 
of the d, b,f, u, and q haplotypes demonstrate that the sequence differences are 
relatively limited and clustered (32). Because the mAb used in our studies were 
derived from an s anti  k immunization,  once the A,  ~ gene sequence is known, 
one can make more precise suggestions as to the exact amino acids involved in 
the binding of the monoclonal antibodies. However, even with the sequence data 
available,  one  can  suggest  that  the  regions  that  determine  reactivity  of the FRELINGER ET  AL.  713 
monoclonais are around amino acids 57 and 75.  This is based on the fact that 
the monoclonal antibodies 40J, 39C, 39F, and 39J react with k hapiotype strains 
but not with d,  b, f, u, and q haplotype strains.  Among these haplotypes, only 
these residues are unique to k haplotype strains. These sites therefore may also 
represent T  cell functional sites. Our studies presented here, combined with the 
recent structural studies, represent the beginning steps in characterizing the sites 
recognized by antibodies and the functional sites of Ia molecules used by T  cells. 
Summary 
Monoclonal antibodies (mAb) were used to inhibit the proliferation of antigen- 
reactive (C57BL6/J  ×  A/J)F1  restricted T  cell clones.  We  have been able  to 
subdivide  these  FI  restricted  T  cell  clones  into  two  groups:  one  of which 
recognizes the A~kAn  b molecule and the other group which recognizes the A~bAn  k 
molecule. Using clones with defined reactivities, we could assign the reactivities 
of monoclonals  to  the  A~  or  An  chains.  By  immunoprecipitation  and  two- 
dimensional analysis of Ia molecules from F~ spleen cells, we could independently 
map the reactivities of the mAb as being determined by the A~ or An chain. To 
date,  these two  methods of chain  localization  of the antibody reactivity have 
agreed. Further, the differential blocking of the A~kAa  b restricted T  cell clones 
suggests that there exists more than one restriction site per Ia molecule. Increas- 
ing the number of possible functional Ia restriction sites, either through combi- 
natorial association of aand/3 chains or by using more than one site per molecule, 
should  increase  the  number  of ways  Ia  molecules  can  function  in  antigen 
presentation. 
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